C
Claudio Jeldres
Researcher at Université de Montréal
Publications - 227
Citations - 9656
Claudio Jeldres is an academic researcher from Université de Montréal. The author has contributed to research in topics: Population & Prostatectomy. The author has an hindex of 54, co-authored 217 publications receiving 8855 citations. Previous affiliations of Claudio Jeldres include Centre Hospitalier Universitaire de Sherbrooke & university of lille.
Papers
More filters
Journal ArticleDOI
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
Marco Bianchi,Maxine Sun,Claudio Jeldres,Shahrokh F. Shariat,Quoc-Dien Trinh,Quoc-Dien Trinh,Alberto Briganti,Z. Tian,Jan Schmitges,Markus Graefen,Paul Perrotte,Mani Menon,F. Montorsi,Pierre I. Karakiewicz +13 more
TL;DR: The proportion of patients with multiple metastatic sites is higher in young patients, and the rates of bone and brain metastases are nonnegligible in mRCC patients.
Journal ArticleDOI
Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample
Quoc-Dien Trinh,Quoc-Dien Trinh,Jesse D. Sammon,Maxine Sun,Praful Ravi,Khurshid R. Ghani,Marco Bianchi,Wooju Jeong,Shahrokh F. Shariat,Jens Hansen,Jan Schmitges,Claudio Jeldres,Craig G. Rogers,James O. Peabody,Francesco Montorsi,Mani Menon,Pierre I. Karakiewicz +16 more
TL;DR: RARP has supplanted ORP as the most common surgical approach for RP and demonstrates superior adjusted perioperative outcomes after RARP in virtually all examined outcomes.
Journal ArticleDOI
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
Laurent Zini,Paul Perrotte,Umberto Capitanio,Claudio Jeldres,Shahrokh F. Shariat,Elie Antebi,Fred Saad,Jean Jacques Patard,Francesco Montorsi,Pierre I. Karakiewicz +9 more
TL;DR: It is shown that partial nephrectomy performed for renal cell carcinoma (RCC) may protect from non‐cancer‐related deaths and the authors tested this hypothesis in a cohort of PN and RN patients.
Journal ArticleDOI
Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma
Naeem Bhojani,Claudio Jeldres,Jean Jacques Patard,Paul Perrotte,Nazareno Suardi,Georg C. Hutterer,Georg C. Hutterer,Francois Patenaude,Stéphane Oudard,Pierre I. Karakiewicz +9 more
TL;DR: Prevention, recognition, and prompt management of side effects are of key importance and avoid unnecessary dose reductions, which may undermine treatment efficacy.
Journal ArticleDOI
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
Firas Abdollah,Firas Abdollah,Giorgio Gandaglia,Giorgio Gandaglia,Rodolphe Thuret,Rodolphe Thuret,Jan Schmitges,Jan Schmitges,Zhe Tian,Claudio Jeldres,Niccolo Passoni,Alberto Briganti,Shahrokh F. Shariat,Paul Perrotte,Francesco Montorsi,Pierre I. Karakiewicz,Maxine Sun +16 more
TL;DR: Little or no change in BCa cancer control outcomes has been achieved during the study period, and virtually all changes in incidence and mortality were minor, and hardly of any clinical importance.